The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on ...

Agentic artificial intelligence took center stage at the HLTH 2025 conference in Las Vegas, and Brigham Hyde, Ph.D., is ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ('Calidi” or the 'Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, ...

Median radiographic progression free survival (“rPFS”) was 9.1 months and the six-month rPFS rate was 67% No patients discontinued study ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the 'Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a late-breaking poster abstract at the ...

– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving complete renal response, and the first dermatomyositis patient maintaining ...

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613's efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a first-in- ...

A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination in preventing cardiovascular events following various viral and bacterial ...